Key Laboratory of Acupuncture and Neurology of Zhejiang Province, The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Hangzhou, China.
Department of Acupuncture, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Front Immunol. 2024 Jun 13;15:1402349. doi: 10.3389/fimmu.2024.1402349. eCollection 2024.
OBJECTIVE: Immunoregulation is a complex and critical process in the pathological process of spinal cord injury (SCI), which is regulated by various factors and plays an important role in the functional repair of SCI. This study aimed to explore the research hotspots and trends of glial cell immunoregulation after SCI from a bibliometric perspective. METHODS: Data on publications related to glial cell immunoregulation after SCI, published from 2004 to 2023, were obtained from the Web of Science Core Collection. Countries, institutions, authors, journals, and keywords in the topic were quantitatively analyzed using the R package "bibliometrix", VOSviewer, Citespace, and the Bibliometrics Online Analysis Platform. RESULTS: A total of 613 papers were included, with an average annual growth rate of 9.39%. The papers came from 36 countries, with the United States having the highest output, initiating collaborations with 27 countries. Nantong University was the most influential institution. We identified 3,177 authors, of whom Schwartz, m, of the Weizmann Institute of Science, was ranked first regarding both field-specific H-index (18) and average number of citations per document (151.44). Glia ranked first among journals with 2,574 total citations. The keywords "microglia," "activation," "macrophages," "astrocytes," and "neuroinflammation" represented recent hot topics and are expected to remain a focus of future research. CONCLUSION: These findings strongly suggest that the immunomodulatory effects of microglia, astrocytes, and glial cell interactions may be critical in promoting nerve regeneration and repair after SCI. Research on the immunoregulation of glial cells after SCI is emerging, and there should be greater cooperation and communication between countries and institutions to promote the development of this field and benefit more SCI patients.
目的:免疫调节是脊髓损伤(SCI)病理过程中的一个复杂而关键的过程,它受多种因素调节,在 SCI 的功能修复中起着重要作用。本研究旨在从文献计量学的角度探讨 SCI 后神经胶质细胞免疫调节的研究热点和趋势。
方法:从 Web of Science 核心合集获取 2004 年至 2023 年发表的有关 SCI 后神经胶质细胞免疫调节的出版物数据。使用 R 包“bibliometrix”、VOSviewer、Citespace 和 Bibliometrics Online Analysis Platform 对主题中的国家、机构、作者、期刊和关键词进行定量分析。
结果:共纳入 613 篇论文,年增长率平均为 9.39%。论文来自 36 个国家,美国的产出最高,与 27 个国家开展合作。南通大学是最有影响力的机构。我们确定了 3177 位作者,其中魏茨曼科学研究所的 Schwartz,m 在领域特定的 H 指数(18)和每篇论文的平均引用次数(151.44)方面均排名第一。Glia 杂志在总引用次数方面排名第一,为 2574 次。关键词“小胶质细胞”、“激活”、“巨噬细胞”、“星形胶质细胞”和“神经炎症”代表了最近的热点,预计将成为未来研究的重点。
结论:这些发现强烈表明,小胶质细胞、星形胶质细胞和神经胶质细胞相互作用的免疫调节作用可能对促进 SCI 后神经再生和修复至关重要。SCI 后神经胶质细胞免疫调节的研究正在兴起,各国和机构之间应加强合作与交流,以促进该领域的发展,使更多的 SCI 患者受益。
Front Immunol. 2024
Front Neurol. 2023-11-21
Neural Plast. 2021
Medicine (Baltimore). 2024-7-19
Spinal Cord. 2022-4
Hum Vaccin Immunother. 2025-12
Neural Regen Res. 2024-8-1
Front Cardiovasc Med. 2023-9-4
Signal Transduct Target Ther. 2023-6-26
Int J Environ Res Public Health. 2023-2-7